Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/1998
07/01/1998CN1185952A Medicine for angiocardiopathy
07/01/1998CN1185948A Inhibitor for generation of 3-deoxyglucurone
07/01/1998CN1038937C Preparation of ergoline-8-carboxamides
07/01/1998CN1038935C Substituted biphenylpyridones and preparation of their salts
07/01/1998CN1038932C Stereoselective preparation of substitued piperidines
07/01/1998CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
06/1998
06/30/1998US5773644 Cyclopropyl alkanoic acid derivatives
06/30/1998US5773620 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present
06/30/1998US5773612 Indol-2-one derivatives
06/30/1998US5773609 In vivo target tissue selectivity
06/30/1998US5773530 Pyrazolopyridine adenosine antagonists
06/30/1998US5773479 Atherosclerosis, tamoxifen
06/30/1998US5773463 Decalcification of brain disorders
06/30/1998US5773455 Inhibitors of prenyl transferases
06/30/1998US5773448 Nervous system disorders
06/30/1998US5773440 Antiinflammatory agent
06/30/1998US5773436 Use of serotonin antagonists for treating fibromyalgia
06/30/1998US5773433 Substituted tetracyclic oxazepine and thiazepine derivatives
06/30/1998US5773432 Using certain 17-difluoromethylene-estratrienes in the treatment and prevention of premature occlusive arterial disease
06/30/1998US5773414 Endothelin antagonists
06/30/1998US5773412 Use of peptides for altering αV β3 -mediated binding
06/30/1998US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/30/1998US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways
06/30/1998US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
06/30/1998US5772629 Tfpi = tissue factor pathway inhibitor
06/30/1998CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta
06/27/1998CA2225906A1 3-deoxyglucosone production inhibitor
06/25/1998WO1998027109A1 Cycloalkyl inhibitors of protein farnesyltransferase
06/25/1998WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors
06/25/1998WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
06/25/1998WO1998027070A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998WO1998026782A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
06/25/1998WO1998019649A3 Methods and compositions for inhibition of angiogenesis
06/25/1998WO1998007449A3 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
06/25/1998CA2275256A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998CA2264207A1 Cycloalkyl inhibitors of protein farnesyltransferase
06/24/1998EP0849266A1 Novel polymorphic form of doxazosin mesylate (form III)
06/24/1998EP0849264A1 Novel polymorphic form of doxazosin mesylate (form I)
06/24/1998EP0849256A1 Amide compounds and use of the same
06/24/1998EP0848755A1 Vegf-related protein
06/24/1998EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
06/24/1998EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
06/24/1998CN1185742A Protein kinase c inhibitors
06/24/1998CN1185737A Isothiazolones
06/24/1998CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same
06/24/1998CN1185331A High-effective Naoxinning-medicine for curing cardio-cerebral disease
06/24/1998CN1185326A Wine for reducing blood-pressure
06/24/1998CN1038840C Para-dinitrogen naphthalene derivative, its preparation method and medical use
06/23/1998US5770772 4-formylamino-2,3,5-trimethyl-1-(2-methyl-2-propenyloxy) -benzene; arteriosclerosis, brain and cardiovascular disorders
06/23/1998US5770735 Neurokinin receptor antagonists
06/23/1998US5770699 Process for production of inhibited forms of activated blood factors
06/23/1998US5770608 Heterocyclic derivatives
06/23/1998US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
06/23/1998US5770581 Gene transcription and ionizing radiation: methods and compositions
06/23/1998US5770578 Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments
06/23/1998US5770575 Nipecotic acid derivatives as antithrombotic compounds
06/23/1998US5770571 Method and agents for inhibiting protein aging
06/23/1998US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide
06/23/1998US5770568 Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process expression vector and recombinant host therefor and pharmaceutical use thereof
06/23/1998US5770565 Peptides for reducing or inhibiting bone resorption
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
06/23/1998CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
06/23/1998CA2033531C Azaoxindole derivatives
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225267A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2224916A1 New polymorphous form of doxazosine mesylate (form 1)
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof
06/18/1998WO1998025921A1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025899A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998WO1998025892A1 Integrin antagonists
06/18/1998WO1998025883A1 Ketobenzamides as calpain inhibitors
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025634A1 Serum-derived factor inducing cell differentiation and medical uses thereof
06/18/1998WO1998025619A1 Novel compounds
06/18/1998WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998WO1998018430A3 P2y receptor antagonists
06/18/1998WO1998016523A3 Selective factor xa inhibitors
06/18/1998WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274655A1 Novel compounds
06/18/1998CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998CA2273988A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998CA2272090A1 Integrin antagonists
06/18/1998CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof
06/17/1998EP0848060A2 Novel human 11CB splice variant
06/17/1998EP0848001A1 Crystalline form of the doxazosin mesylate and process for its production
06/17/1998EP0847999A1 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them
06/17/1998EP0847996A1 Sulfonamide substituted compounds as K-channel blockers
06/17/1998EP0847276A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1595